|
Volumn 101, Issue 24, 2009, Pages 1732-1733
|
Re: Dose escalation methods in phase i cancer clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER THERAPY;
DOSE RESPONSE;
DRUG DOSE ESCALATION;
LETTER;
MAXIMUM TOLERATED DOSE;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
RESEARCH DESIGN;
|
EID: 72649102710
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djp400 Document Type: Letter |
Times cited : (5)
|
References (7)
|